Introduction {#s0001}
============

Benefits of essential oil stem from their reported medicinal uses as antioxidant, antimicrobial and anti-inflammatory properties (Eldahshan [@CIT0010]; Salleh et al. [@CIT0030]; Eldahshan & Halim [@CIT0011]; Omri Hichri et al. [@CIT0026]). *Cinnamomum* (Lauraceae) is a genus of evergreen shrubs and trees. It contains over 250 species, distributed in tropical and subtropical regions of America, Asia, Oceania, and Australasia (Krikorian [@CIT0020]; Kirtikar & Basu [@CIT0019]). Some Leaves of *Cinnamomum* species worldwide have been subjected to volatile oil analysis, where their volatile oil constituents revealed different compositional patterns. For example, *Cinnamomum tamala* T. Nees & Eberm. from India, the major components in hydrodistilled oil are *trans*-sabinene hydrate, (*Z*)-*β*-ocimene, and germacrene A (Mir et al. [@CIT0022]). Several chemotypes of *Cinnamomum tamala* volatile oil in Uttarakhand showed that linalool, 1,8-cineole, cinnamyl acetate, *E*-cinnamaldehyde and eugenol were in major quantities (Agrawal et al. [@CIT0002]).

The volatile oil of *Cinnamomum zeylanicum* Blume (Lamiaceae) leaves of Pantnagar contains linalool, *E*-cinnamaldehyde and *E*-cinnamyl acetate. While the essential oil of *C. zeylanicum,* in South Indian, showed dominance of eugenol (Agrawal et al. [@CIT0002]). Indian *C. zeylanicum* buds, revealed that *α-*bergamotene and α-copaene are the major constitutes (Jayaprakasha et al. [@CIT0014]).

Analysis of essential oil of *Cinnamomum camphora* (L.) J. Presl, from Uttarakhand, revealed the presence of a camphor as a single major constituent (Agrawal et al. [@CIT0002]). Meanwhile, GC analysis of essential oil of *Cinnamomum camphora* cultivated at Medicinal Plant Resources and Development Centre (MRDC) at Uttarakhand, India, revealed the presence of a camphor as a single major constituent (Agrawal et al. [@CIT0002]). The major components present in the Fijian *C. verum* J. Presl leaf volatile oils were eugenol, (*E*)-caryophyllene and linalool in the Indian sample (Patel et al. [@CIT0027]). On the other hand, major compound in *Cinnamomum pauciflorum* Nees, leaves essential oil in northeast India was (*E*)-cinnamaldehyde (Nath et al. [@CIT0024]).

*Cinnamomum glanduliferum* is large-sized evergreen tree species native to the tropical Himalayan regions of India and Nepal. In northern India, It occurs naturally in both the hills and plains up to an altitude of 1200 m and is known as 'Gondsoroi tree.' Almost all parts of the plants are aromatic (Finnemore [@CIT0012]). In India, 2 chemotypes *C. glanduliferum* leaves were identified; the 1st could be characterized by the dominance of (*E*)-nerolidol, followed by caryophyllene oxide (Baruah & Nath [@CIT0006]). The 2nd chemotype oils of *C. glanduliferum,* contains cineole as the major component (Chowdhury [@CIT0008]). The leaves were used as carminative and stimulant (Pullaiah [@CIT0028]).

Carrageenan-induced oedema model was used in this study to evaluate the potential anti-inflammatory effect of CG oil. Oedema due to carrageenan injection is presumed to be through inflammatory mediators that increase vascular permeability and/or increase blood flow (Ialenti et al. [@CIT0013]). On the other hand, ethanol-induced gastric ulcer and gastritis is a widely used experimental model for evaluation of gastroprotective activity. Ethanol is well known as a damaging agent to the stomach that acts by a direct necrotizing action, which in turn decreases bicarbonate secretion and mucus production. Thus, the ethanol-induced gastric damage may be related to the generation of reactive species, reduced cell proliferation, and an exacerbated inflammatory response (Amaral et al. [@CIT0004]).

In a previous study, *C. glanduliferum* bark volatile oil in Egypt was subjected to GC-MS analysis (Taha & Eldahshan [@CIT0035]) but leaf and stem have not been studied for yet. Thus our aim in this study was phyto-investigation of its volatile oil (leaves and green branches) as well as the anti-inflammatory and gastroprotective effects of the volatile oil in leaves.

Materials and methods {#s0002}
=====================

Plant material {#s0003}
--------------

*Cinnamomum glanduliferum*, leaves and green branches, were collected from Al-Zohria Garden, Cairo, Egypt in February 2014. The species was authenticated by Dr. Usama K. Abdel Hameed, Department of Botany, Faculty of Science, Ain Shams University, Cairo, Egypt. A voucher specimen (voucher specimen number; PHG-P-CG-152) is deposited at Pharmacognosy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

Isolation of volatile oils {#s0004}
--------------------------

The *C. glanduliferum* plant material was chopped into small pieces. The essential oil was isolated from each part by hydro-distillation (5 h) using a Clevenger-type all glass apparatus. The oil was transferred to a screw-capped glass vial, dried over anhydrous sodium sulphate and stored at 4 °C in the dark.

Analysis of volatile oils by GC and GC-MS {#s0005}
-----------------------------------------

GC analysis was carried out using a GC HP 5890 Hewlett Packard equipped with FID and HP-5 fused silica capillary column (30 m × 0.25 mm i.d., film thickness 0.25 μm). Sample volume; 0.03 μL. Oven temperature was programed from 60 °C to 240 °C at 3 °C/min; injector temperature, 250 °C; detector temperature, 280 °C; carrier gas, helium (1.0 mL/min); automatic sample injection, 0.02 μL of the oil; split: 1/70. The relative proportions of the essential oil constituents were expressed as percentages obtained by peak area normalization. GC--MS analysis was performed on a Perkin-Elmer quadrupole MS system (Model 5) coupled with the GC HP 5972, equipped with a HP-5 capillary column. Oven temperature was programed from 45 °C to 240 °C at 3 °C/min; injector temperature, 250 °C; carrier gas, helium (0.5 mL/min); automatic sample injection, 0.02 μL of the oil; split: 1/70. The MS operating parameters were: interface temperature: 300 °C, ion source temperature: 200 °C, EI mode: 70 eV, scan range: 41--400 amu.

Compounds identification {#s0006}
------------------------

Mass spectra of the individual GC peaks were identified by a computer search of the commercial libraries (WILEY, NIST). The identification was further confirmed by the calculation of the retention indices (RI) relative to (C~6~-C~22~) *n*-alkanes (Adams [@CIT0001]).

Chemicals {#s0007}
---------

Indomethacin was purchased from Sigma-Aldrich (St. Louis, MO). Inflammatory-grade carrageenan was purchased from FMC (Rockland, ME). Ethanol was obtained from El-Nasr chemical Co., Egypt. PGE2 ELISA (Abnova Co., Walnut, CA) and COX-2 activity colorimetric assay kits were purchased from Cayman Co. (Ann Arbor, MI). All other chemicals used were of analytical grade.

Animals {#s0008}
-------

In this study, 60 male Wistar albino rats, with a mean weight of 150--170 g were obtained from the animal house of the National Central Institute; Dokki, Cairo, Egypt and allowed to acclimatize to their environment for 1 week before the experiment. The rats were housed in stainless-steel cages (eight animals per cage) and kept on 12 h light/dark cycle and constant environmental conditions. The rats were allowed to free access to water and food (fed on standard pellet). All efforts were made to minimize animal pain or suffering during experimentation. The study was conducted according to regulations of the ethics committee of the National Research Centre which gave its consent in accordance with the National Regulations on Animal Welfare and Institutional Animal Ethical Committee.

Determination of median lethal dose (LD~50~) {#s0009}
--------------------------------------------

Five groups of six rats each received volatile oil in doses ranging from 1 to 4 g/kg body weight. The toxic symptoms, mortality rate, and postmortem findings in each group were recorded 24 h after administration. The LD~50~ of the tested extract was calculated according to the following formula: $$\text{LD}_{\text{5}0} = \frac{D_{\text{m}} - \sum\ z \times d}{N}$$where, *D*~m~ means the largest dose that kills all animals; *z* means the mean of dead animals between two successive groups; *d* means the constant factor between two successive doses; *N* means the number of animals in each group; ∑ means the sum of *z* × *d*. One fifth, one tenth and one twentieth of the maximum dose (5 g/kg body weight) of the plant extract that did not cause mortalities or toxic symptoms in rats were chosen to be used for the biological investigation throughout the study.

Study groups of acute anti-inflammatory test {#s0010}
--------------------------------------------

Animals were divided into five groups (six rats each). The first group served as control and received normal saline. The second group was administered with indomethacin (10 mg/kg *p.o.*) as the standard anti-inflammatory drug. The third, fourth and fifth groups received the volatile oil at doses of 250, 500 and 1000 mg/kg body weight *p.o*., respectively. One hour after the oral administration of the extract, all the animals were injected with 0.1 mL of 1% (v/v) carrageenan solution in saline subcutaneously at the sub-planter area of the right hind paw. The paw volume of each rat was measured using planimeter before carrageenan injection and then followed by hourly measurement up to 4 h post carrageenan administration. The percent change in paw volume compared to base line measurement was taken as the criteria of comparison and was calculated as follows; where, *V*~o~ is the paw volume before carrageenan injection (mL); *V*~t~ is the paw volume at *t* hour after carrageenan injection (mL): $$\text{Edema}\ \% = \frac{V_{\text{t}} - V_{\text{o}}}{V_{\text{o}}} \times 100$$

Percent of inhibition of paw oedema was also calculated as follows; where, *E*~c~ is the oedema of control group; *E*~t~ is the oedema of volatile oil-treated group: $$\text{Percent\ inhibition} = \frac{E_{\text{c}} - E_{\text{t}}}{E_{\text{t}}} \times 100$$

Examination of serum COX-2 and PGE2 level {#s0011}
-----------------------------------------

COX-2 was assessed using a readymade colorimetric kit (Cayman co., Ann Arbor, MI) and the results were expressed as nmole/min/mL. PGE2 was also measured by ELISA kit (Abnova Co., Walnut, CA), and the results were expressed as pg/mL.

Induction of gastritis in rats {#s0012}
------------------------------

Animals were divided into five groups (six rats each). One group received saline as control; the second group received famotidine (50 mg/kg) and the three remaining groups received the volatile oil at doses of 250, 500 and 1000 mg/kg body weight *p.o*., respectively. One hour later, gastric lesion was induced in rats by intragastric administration of 1 mL ethanol (99% v/v) to rats that had been fasted for 18 h with access to water *ad lib* in a slight modification to the method described by Al-Shabanah ([@CIT0003]).

Rats were sacrificed one hour after ethanol administration by cervical dislocation after being lightly anesthetized with ether. Stomach of experimental rats was excised, washed with saline, and were used for histopathological examination and biochemical studies.

Gastritis-histopathological evaluation {#s0013}
--------------------------------------

The collected stomach specimens were immersed directly into 10% neutral buffered formalin for 4 weeks. The formalin-preserved samples were continuously transferred to freshly prepared fixative every week. Fixed samples were briefly rinsed into 70% ethanol for 24 h, then dehydrated through a graded series of ethanol (75, 80, 90, 95%, absolute alcohol I, II and III) at 4 h intervals, cleared in three changes of xylene (2 h each), then embedded in paraffin wax (melting point 60 °C) forming paraffin blocks. The specimens were serially sectioned at 5--7 μm thickness. The prepared sections were stained using Harris heamatoxylin and Eosin (H & E). The severity of histopathological alteration in stomach samples of different experimental rat groups were scored by an independent observer.

Evaluation of nitric oxide content {#s0014}
----------------------------------

Nitric oxide produced in gastric tissue samples was evaluated spectrophotometrically using the method of Miranda et al. ([@CIT0023]). Total NO tissue content was calculated based on a standard curve constructed using sodium nitrate and was expressed as μM nitrate/g tissue.

Assessment of lipid peroxidation {#s0015}
--------------------------------

Stomach samples were stored immediately at −20 °C until analysis. Tissue samples were homogenized in 1 mL of 10 mmol/L Tris-HCl buffer of pH 7.1 and homogenate was used for further biochemical analysis. The stomach lipid peroxidation was evaluated by measurement of gastric MDA content according to Mihara and Uchiyama ([@CIT0021]).

Statistical analysis {#s0016}
--------------------

All data are expressed as mean ± standard error of the mean (S.E.M.) of six rats per experimental group. Statistical analysis was performed using Instat 3.06 statistical software package. Parametric oneway analysis of variance (ANOVA) followed by Tukey--Kramer Multiple Comparisons Test was used to compare the mean values of quantitative variables among the groups. The minimal level of significance was identified at *p* \< 0.05.

Results {#s0017}
=======

Chemical composition of essential oils {#s0018}
--------------------------------------

[Table 1](#t0001){ref-type="table"} revealed qualitative similarities between both oils but they are quantitatively different. The yield of leaves oil was 1.00% v/w while that of branches was 0.1% v/w. Twenty-five compounds were identified from leaves oil (98.85% of the total detected components). The major constituents of the oil were eucalyptol (59.44%) followed by sabinene (14.99%), *α*-terpineol (6.44%), *α*-pinene (5.27%), *β*-pinene (3.75%). Terpine-4-ol and *α*-humulene were present in considerable amount. *trans*-Sabinene hydrate was not detected in branches. Some sesquiterpenes were present in low amounts in leaves oil and not detected in the oil of branches as *β*-elemene, germacrene D, germacrene B, spathulenol and globulol.

###### 

Essential oil composition of *Cinnamomum glanduliferum* leaf and green branches.

  No.                               Formula                                           Compounds                                          Leaves Oil   KI         Stem Oil
  --------------------------------- ------------------------------------------------- -------------------------------------------------- ------------ ---------- -----------
  1                                 C~10~H~16~                                        *α*-Thujene[\*](#TF2){ref-type="table-fn"}         0.79         923        0.69
  **2**                             **C~**10**~H~**16**~**                            ***α*-Pinene**[\*](#TF2){ref-type="table-fn"}      **5.27**     **930**    **4.71**
  3                                 C~10~H~16~                                        Camphene[\*](#TF2){ref-type="table-fn"}            0.22         944        0.25
  **4**                             **C~10~H~16~**                                    **Sabinene[\*](#TF2){ref-type="table-fn"}**        **14.99**    **966**    **7.12**
  **5**                             **C~10~H~16~**                                    **β-Pinene[\*](#TF2){ref-type="table-fn"}**        **3.75**     **973**    **3.09**
  6                                 C~10~H~16~                                        β-Myrcene[\*](#TF2){ref-type="table-fn"}           0.76         985        0.93
  7                                 C~10~H~16~                                        δ-2-Carene                                         0.12         1000       0.95
  8                                 C~10~H~16~                                        *α*-Terpinene[\*](#TF2){ref-type="table-fn"}       0.54         1012       1.88
  9                                 C~10~H~16~                                        *p*-Cymene[\*](#TF2){ref-type="table-fn"}          0.05         1018       1.27
  10                                C~10~H~16~                                        Limonene[\*](#TF2){ref-type="table-fn"}            0.44         1022       1.30
  **11**                            **C~10~H~18~O**                                   **Eucalyptol[\*](#TF2){ref-type="table-fn"}**      **59.44**    **1024**   **55.74**
  12                                C~10~H~16~                                        γ-Terpinene[\*](#TF2){ref-type="table-fn"}         0.86         1055       2.88
  13                                C~12~H~20~O~2~                                    *Cis*-Sabinene hydrate                             0.39         1064       0.16
  14                                C~10~H~16~                                        Terpinolene[\*](#TF2){ref-type="table-fn"}         0.13         1083       0.48
  15                                C~12~H~20~O~2~                                    *trans*-Sabinene hydrate                           0.21         1095       *n.d.*
  16                                Unidentified                                      --                                                 0.06         --         *n.d.*
  17                                Unidentified                                      --                                                 0.66         --         0.87
  18                                C~10~H~18~O                                       Terpinene-4-ol[\*](#TF2){ref-type="table-fn"}      1.86         1175       5.75
  **19**                            **C~10~H~18~O**                                   ***α*-Terpineol[\*](#TF2){ref-type="table-fn"}**   **6.44**     **1184**   **9.81**
  20                                C~15~H~24~                                        *β*-Elemene                                        0.05         1385       *n.d.*
  21                                C~15~H~24~                                        *trans*-Caryophyllene                              0.5          1415       0.64
  22                                C~15~H~24~                                        *α*-Humulene[\*](#TF2){ref-type="table-fn"}        1.65         1448       1.16
  23                                C~15~H~24~                                        Germacrene D                                       0.17         1480       *n.d.*
  24                                Unidentified                                      --                                                 0.25         --         *n.d.*
  25                                C~15~H~24~                                        Germacrene B                                       0.08         1556       *n.d.*
  26                                C~15~H~24~O                                       Spathulenol                                        0.05         1575       *n.d.*
  27                                C~15~H~24~O                                       Caryophyllene oxide                                0.04         1580       0.32
  28                                Unidentified                                      --                                                 0.11         --         *n.d.*
  29                                Unidentified                                      --                                                 0.07         --         *n.d.*
  30                                C~15~H~26~O                                       Globulol                                           0.05         1592       *n.d.*
                                    **Total peak (%, No. of identified compounds)**                                                                              
  **Functional group**              **Leaves (33)**                                   **Branches (24)**                                                          
  Monoterpene Hydrocarbons          27.92 (12)                                        25.55 (12)                                                                 
  Sesquiterpene Hydrocarbons        2.45 (5)                                          1.8 (2)                                                                    
  Oxygenated monoterpenes           68.34 (5)                                         71.46 (4)                                                                  
  Oxygenated sesquiterpenes         0.14 (3)                                          0.32 (1)                                                                   
  **Total hydrocarbon compounds**   30.37                                             27.35                                                                      
  **Total oxygenated compounds**    68.48                                             71.78                                                                      
  **Total**                         98.85                                             99.13                                                                      

Values are expressed as relative area percentage; n.d: Not detected; The major components are highlighted in bold. (Values expressed as relative area percentages to the total identified components).

Compounds previously reported in the bark (Taha & Eldahshan [@CIT0035]).

Oil of branches is pale yellow in colour. Twenty peaks were identified which represent 99.13% of the total detected constituents. Eucalyptol represents also the major peak (55.74%) followed by *α*-terpineol (9.81%), sabinene (7.12%), terpine-4-ol (5.75%) and *α*-pinene (4.71%), β-pinene (3.09%) and γ-terpinene (2.88%). Other components as *α*-terpinene, limonene, *p*-cymene and *α*-humulene were present in \<2%. The oil of leaves was characterized by presence of higher amount of eucalyptol, sabinene and *α*-pinene than those in the branches while the latter is characterized by the presence of higher amount of *α*-terpineol, 4-terpineol and γ-terpinene than leaves.

Rat paw oedema model {#s0019}
--------------------

Intraplantar injection of 0.1 mL of 1% carrageenan successfully established the oedema experimental model resulting in significant increase in the mean volume of the challenged paw compared to that of the untreated paws (159% of the untreated paws following 4 h post carrageenan administration, [Figure 1](#F0001){ref-type="fig"}). Pretreatment of rats with volatile oil at different doses of 250, 500 and 1000 mg/kg significantly inhibited the carrageenan-induced increase in the oedema volume of the paws after 1, 2, 3 and 4 h ([Table 2](#t0002){ref-type="table"}). Following 4 h of carrageenan challenge, doses of 250, 500 and 1000 mg/kg significantly reduced the paw volume to 94, 82 and 69% change, respectively. However, indomethacin-treated group showed more significant anti-oedema effect (31.5% of the challenged paws).

![Time and dose-dependent effects of volatile oil in carregenin-induced rat oedema model. Each value represents mean % change of paw oedema volume ± SEM (*n* = 6). Statistical analysis was carried out by One-way ANOVA followed by Tukey post hoc test. a: Statistical significance as compared to the control. b: Statistical significance as compared to the Dose 250 treated group. c: Statistical significance as compared to the indomethacin treated group.](IPHB_A_1314512_F0001_C){#F0001}

###### 

Effects of ascending doses of volatile oil (250, 500 and1000 mg/kg, *p.o*.) on carrageenan-induced rat paw oedema model.

                 Time interval                                                                                                                                                                                                                                                                                                                                                                         
  -------------- ----------------------------------------------------------------------------- ------- ------------------------------------------------------------------------------- --------- ------------------------------------------------------------------------------ -------- ------------------------------------------------------------------------------------------------------------- --------
  Control        95.9 ± 9.6[^b^](#TF5){ref-type="table-fn"}^,[c](#TF6){ref-type="table-fn"}^   --      125.7 ± 10.5[^b^](#TF5){ref-type="table-fn"}^,[c](#TF6){ref-type="table-fn"}^   --        153.3 ± 9.1[^b^](#TF5){ref-type="table-fn"}^,[c](#TF6){ref-type="table-fn"}^   --       155.8 ± 8.75[^b^](#TF5){ref-type="table-fn"}^,[c](#TF6){ref-type="table-fn"}^                                 --
  Indomethacin   26.9 ± 2.6^[a](#TF4){ref-type="table-fn"}^                                    72%     27.9 ± 3.2^[a](#TF4){ref-type="table-fn"},[b](#TF5){ref-type="table-fn"}^       77.8%     31.8 ± 0.78^[a](#TF4){ref-type="table-fn"},[b](#TF5){ref-type="table-fn"}^     79.25%   31.5 ± 3.5^[a](#TF4){ref-type="table-fn"},[b](#TF5){ref-type="table-fn"}^                                     79.79%
  Dose 250       45.6 ± 9.6^[a](#TF4){ref-type="table-fn"}^                                    52.5%   76.6 ± 3.2^[a](#TF4){ref-type="table-fn"},[c](#TF6){ref-type="table-fn"}^       39%       86.5 ± 5[^a^](#TF4){ref-type="table-fn"}^,[c](#TF6){ref-type="table-fn"}^      43.6%    93.75 ± 1.3^[a](#TF4){ref-type="table-fn"},[c](#TF6){ref-type="table-fn"}^                                    39.8%
  Dose 500       44.5 ± 4.5^[a](#TF4){ref-type="table-fn"}^                                    53.5%   53.9 ± 1.1^[a](#TF4){ref-type="table-fn"},[c](#TF6){ref-type="table-fn"}^       57.1% 5   75.36 ± 3.9[^a^](#TF4){ref-type="table-fn"}^,[c](#TF6){ref-type="table-fn"}^   50.85%   81.6 ± 3.3^[a](#TF4){ref-type="table-fn"},[c](#TF6){ref-type="table-fn"}^                                     47.65%
  Dose 1000      43.9 ± 6.9^[a](#TF4){ref-type="table-fn"}^                                    54.2%   48.9 ± 6.5^[a](#TF4){ref-type="table-fn"},[b](#TF5){ref-type="table-fn"}^       61.1%     64.5 ± 7.4[^a^](#TF4){ref-type="table-fn"}^,[c](#TF6){ref-type="table-fn"}^    57.9%    69.14 ± 1.9[^a^](#TF4){ref-type="table-fn"}^,[b](#TF5){ref-type="table-fn"},[c](#TF6){ref-type="table-fn"}^   55.6%

Each value represents mean % change of paw oedema volume ± SEM (*n* = 6). Statistical analysis was carried out by One-way ANOVA followed by Tukey post hoc test.

Statistical significance as compared to the control.

Statistical significance as compared to the dose 250 mg/kg treated group.

Statistical significance as compared to the indomethacin-treated group.

Inflammatory markers {#s0020}
--------------------

Regarding the serum inflammatory markers, indomethacin treatment after 4 h of carrageenan injection significantly reduced COX-2 activity (42.4 ± 8.5 nmol/min/mL) compared to that untreated animals in group I (104.6 ± 8.3 nmol/min/mL). Volatile oil application in doses of 250, 500 and 1000 mg/kg showed significant reduction of COX-2 activity by 1.4, 2.1 and 4.9 folds to reach 73.8, 50.7and 21.4 nmol/min/mL, respectively, compared to group I ([Figure 2(A)](#F0002){ref-type="fig"}). On the other hand, indomethacin treated animals in group II resulted in mean PGE2 concentration of 2.1 ± 0.3 pg/mL in inflammatory exudates compared to group I of carrageenan challenge that resulted in 4.4 ± 0.5 ([Figure 2(B)](#F0002){ref-type="fig"}). Animals receiving volatile oil showed significant reduction of the PGE2 concentration by 1.5, 1.8 and 2.5 folds (to reach 2.95 ± 0.2, 2.45 ± 0.15 and 1.75 ± 0.015 pg/mL) for the doses of 250, 500 and 1000 mg/kg, respectively).

![Effect of different doses of volatile oil on COX II (A) & PGE2 (B) serum levels. a: Statistical significance as compared to the control. b: Statistical significance as compared to the dose 250 treated group.](IPHB_A_1314512_F0002_C){#F0002}

Histopathological study of the gastritis model {#s0021}
----------------------------------------------

Focal inflammatory cells infiltration with dilatation in the blood vessels was detected in the submucosa of the control group ([Figure 3(A)](#F0003){ref-type="fig"}). There was no histopathological alteration and the normal histological structure of the mucosa, submucosa, muscularis and serosa were recorded in the famotidine group ([Figure 3(B)](#F0003){ref-type="fig"}). The submucosa showed focal inflammatory cells infiltration in the group treated with dose 250 mg/kg ([Figure 3(C)](#F0003){ref-type="fig"}). Focal few inflammatory cells infiltration with dilatation in the blood vessels were recorded in the submucosa in the group treated with dose 500 mg/kg ([Figure 3(D)](#F0003){ref-type="fig"}). There were very few inflammatory cells infiltration in the base of the mucosa in the group treated with dose 1000 mg/kg ([Figure 3(E)](#F0003){ref-type="fig"}). Scoring of the gastric lesion (non-ulcerative focal acute gastritis) was compared and described in the different experimental groups ([Figure 3(F)](#F0003){ref-type="fig"}).

![Photomicrographs of stomach sections of different treatment groups stained by H&E. A: Control group (vehicle treated) showing focal inflammatory cells infiltration with dilated blood vessels in submucosa (×40). B: Famotidine treated group showing normal submucosa (×40). C: Dose 250 mg/kg treated group showing focal inflammatory cells infiltration in submucosa (×40). D: Dose 500 mg/kg treated group showing focal inflammatory cells infiltration with dilated blood vessels in submucosa (×40). E: Dose 1000 mg/kg treated group showing focal inflammatory cells infiltration in base of mucosa (×40). F: Scoring the severity of the histopathological alterations (Focal inflammatory cells infiltration with dilated blood vessels in submucosa) in stomach of different experimental groups. +++: Severe histopathological alteration. ++: moderate histopathological alteration. +: mild histopathological alteration. --: nil histopathological alteration.](IPHB_A_1314512_F0003_C){#F0003}

Oxidative stress markers {#s0022}
------------------------

Regarding the tissue oxidative stress markers, famotidine treatment 1 h before ethanol intragastric administration reduced NO concentration (34.9 ± 0.7 μM nitrate/g) compared to that of untreated animals in group I (98.9 ± 2.6 μM nitrate/g). Volatile oil adminstration in doses of 250, 500 and 1000 mg/kg showed significant reduction of NO concentration by 3.1, 2.7 and 2.4 folds to reach 32, 37 and 41 μM nitrate/g respectively compared to group I ([Figure 4(A)](#F0004){ref-type="fig"}). On the other hand, famotidine treated animals in group II resulted in mean MDA concentration of 1.15 ± 0.08 nmol/g in inflammatory exudates as compared to group I of ethanol challenge that resulted in 2.3 ± 0.08 ([Figure 4(B)](#F0004){ref-type="fig"}). Animals receiving volatile oil showed significant reduction of the MDA concentration by 2, 2.1 and 2.2 folds (to reach 1.15, 1.11 and 1.04 nmol/g) for the doses of 250, 500 and 1000 mg/kg, respectively).

![Effect of different doses of volatile oil on NO (A) & MDA (B) gastric tissue levels. a: Statistical significance as compared to the control. b: Statistical significance as compared to the Dose 250 treated group.](IPHB_A_1314512_F0004_C){#F0004}

Discussion {#s0023}
==========

The present study shows a comparison of the composition of the volatile oil of leaves and green branches of *C. glanduliferum* as well as evaluation of the potential anti-inflammatory activity of volatile oil of leaves (higher yield) in carrageenan-induced rat oedema model. Oedema due to carrageenan injection is presumed to be through inflammatory mediators that increase vascular permeability and/or increase blood flow (Ialenti et al. [@CIT0013]). Thus, the effect of volatile oil may be attributed to the effect of the volatile oil on the inflammatory mediators and also on the pathway of prostaglandins synthesis.

CG volatile oil caused a time-dependent reduction of carrageenan-induced rat paw oedema. Following 4 h of treatment, volatile oil of leaves at doses 250, 500 and 1000 mg/kg caused a significant inhibition of rat paw oedema volume by 40%, 48% and 56%, respectively, in comparison to the control group. Such conclusion was further confirmed by assessing COX-2 activity and serum PGE2 level in the same model. Prostaglandins have been long recognized as a major mediator of inflammation. They are arachidonic acid metabolites synthesized by COX-1 and COX-2 isozymes (Herschman [@CIT0017]). Our results indicate that the volatile oil caused statistically significant reduction of COX-2 activity and serum PGE2 concentration. This finding clearly underlines the anti-inflammatory effect of the tested volatile oil, where the effect of volatile oil may be attributed to the influence of the volatile oil on the inflammatory mediators and also on the pathway of prostaglandins synthesis.

The major components of leaves volatile oil is 1,8-cineole (59.44%) which is known as eucalyptol or cajeputol. It consists of 2 isoprene units (C10) which is structurally related in to human isoprenoid as tocopherols (C20) and steroid hormones (C30). Our results agree with Singh et al. ([@CIT0033]), where the major component identified from CG leaves grown in India was 1,8-cineole (41.42%).

Many reports provided evidences that eucalyptol possesses anti-inflammatory activity, gastroprotective and ulcer healing effect. Thus, it could inhibit carrageenan oedema, increased capillary permeability and granuloma formation (Santos & Rao [@CIT0031]). Moreover, it exhibited a steroid-like suppression of arachidonic acid metabolism and cytokine production *in vitro* (Juergens et al. [@CIT0015], [@CIT0016]). The chemical relationship between eucalyptol and glucocorticosteroids (human isoprenoid; C20), explains that there is a common mechanism of anti-inflammatory mediator suppression for their anti-inflammatory effect and this was obvious in its ability to inhibit the formation of inflammatory mediators as cytokines (TNFa, IL1-b), leukotriene B4, thromboxane B2 and prostaglandin E2 (Juergens et al. [@CIT0015], [@CIT0016]).

On the other hand, the present results show that CG volatile oil could protect against gastric lesions and gastritis induced by ethanol administration. This was confirmed by histopathological investigation as well as reduction of NO & MDA tissue levels. This effect could be attributed to the presence of eucalyptol in high percent. Eucalyptol itself is an important gastroprotective agent. The suggested mechanisms of action are explained through cytoprotective mechanism (causing an increase in gastric mucus), antioxidant activity (preventing depletion of sulfhydryl groups and reducing levels of lipid peroxidation and myeloperoxidase activity in the gastric mucosa) and finally healing ability (Rocha Caldas et al. [@CIT0029]).

Santos and Rao reported that 1,8-cineole prevented ethanol-induced gastric injury in rats where the antioxidant and lipoxygenase inhibitory actions are of prime importance in affording gastroprotection against ethanol injury in the rat (Santos & Rao [@CIT0032]). Other essential oils whose main constituent is eucalyptol as *Hyptis martiusii* Benth (Lamiaceae) exibited gastroprotective effect in various gastric lesion models in rats. The mechanism was through an antisecretory activity mediated by the histamine H2 and gastrin CCK2 receptors, hence reduces levels of lipid peroxidation and also increase the healing of chronic ulcers promoting significant regeneration of the gastric mucosa (Caldas et al. [@CIT0007]).

Furthermore, *C. glanduliferum* oil contains also other anti-inflammatory constituents in considerable amounts*. Citrus reticulate* Blanco (Rutaceae) and *Zornia diphylla* (L.) Pers (Fabaceae) volatile oils showed anti-inflammatory effect as sabinene is the major compound in both (34.75% and 43.1%) (kim et al. [@CIT0018]; ArunKumar et al. [@CIT0005]). Terpinene-4-ol exhibited anti-inflammatory activity *in vitro* and *in vivo* (Ninomiya et al. [@CIT0025]). α-Pinene also exerts a role in the management of inflammatory process (De Cassia da Silveira e Sa et al. [@CIT0009]). α-Pinene (50.8%) and cineole (20.3%) are the major components of *Hyptis spicigera* Lam. (Lamiaceae) essential oil which exhibited antiulcerogenic and gastroprotective actions in the gastric mucus production induced by PGE2 levels. A healing activity was produced with 87% reduction in ulcerative lesion area. It increased COX-2 (75%) and EGF (115%) expression in gastric mucosa so increase the healing of acetic acid-induced gastric lesions (Takayama et al. [@CIT0036]). α-Terpineol exhibited gastroprotective activity against ethanol-induced ulcers. It showed gastroprotective activity which does not involve a decrease in the gastric acid secretion or an increase in the synthesis of endogenous prostaglandin (Souza et al. [@CIT0034]).

In conclusion, for the first time, volatile oil of *C. glanduliferum* leaves was shown to possess a potent anti-inflammatory activity as well as gastroprotective effect at the tested doses (250, 500 and 1000 mg/kg). This is evidenced by reducing paw oedema, COX-2 activity and PGE2 content. Furthermore, in ethanol-induced animal model, as evidenced by histopathologic examination volatile oil exhibited gastroprotective effect and also managed to reduce NO content and MDA levels in the gastric homogenate. These anti-inflammatory and gastroprotective effects are possibly attributed to the synergistic effect of special components in the oil specially eucalyptol (high percent), and others as sabinene and α-pinene. *Cinnamomum glanduliferum* could also be used as a good source of 1,8-cineole for medical purpose.
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